JZP-361 is a specific MAGL inhibitor with IC50s of 46 nM, 7.24 µM, and 1.79 µM for human recombinant MAGL, human recombinant FAAH, and human hABHD6. JZP-361 displays anti-histaminergic activities. JZP-361 can be used in studies about asthma.
Molecular Weight:
405.88
Purity:
99.82%
CAS Number:
[1680193-80-9]
Formula:
C22H20ClN5O
Target:
MAGL|||Histamine Receptor|||Lipase
T27703
* VAT and and shipping costs not included. Errors and price changes excepted
